236 related articles for article (PubMed ID: 31964206)
1. Minimum inhibitory concentration changes in relapsed left ventricular assist device driveline infections.
Lines TH; Sabato LA; Nesbitt WJ; Moretz JD; Brinkley DM; Satyanarayana G
Int J Artif Organs; 2020 Jul; 43(7):494-499. PubMed ID: 31964206
[TBL] [Abstract][Full Text] [Related]
2. Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome.
Bomholt T; Moser C; Sander K; Boesgaard S; Køber L; Olsen PS; Hansen PB; Mortensen SA; Gustafsson F
Scand Cardiovasc J; 2011 Oct; 45(5):273-8. PubMed ID: 21539474
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Success With Driveline Exit Site Relocation for Deep Driveline Infection in Left Ventricular Assist Device Patients.
Balsam LB; Jacoby A; Louie E; Levine JP
Innovations (Phila); 2017; 12(6):440-445. PubMed ID: 29232297
[TBL] [Abstract][Full Text] [Related]
4. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.
Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH
Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular assist device-related infections: does the time of onset matter?
Lehnert AL; Hart A; Brouse SD; Charnigo RJ; Branam S; Guglin ME
J Artif Organs; 2019 Jun; 22(2):98-103. PubMed ID: 30386926
[TBL] [Abstract][Full Text] [Related]
6. Nontuberculous mycobacterial infections in left ventricular assist device patients.
Radcliffe C; Doilicho N; Grant M
J Card Surg; 2020 May; 35(5):1138-1141. PubMed ID: 32253770
[TBL] [Abstract][Full Text] [Related]
7. Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant.
Peghin M; Maiani M; Castaldo N; Givone F; Righi E; Lechiancole A; Sartor A; Pea F; Livi U; Bassetti M
Infection; 2018 Apr; 46(2):263-265. PubMed ID: 29086895
[TBL] [Abstract][Full Text] [Related]
8. Late driveline left ventricular assist device infection treated with frozen-and-thawed allogeneic platelet gel.
Formica F; Perseghin P; Cirò A; Paolini G
Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):523-5. PubMed ID: 24920760
[TBL] [Abstract][Full Text] [Related]
9. Prospective, multicenter study of ventricular assist device infections.
Gordon RJ; Weinberg AD; Pagani FD; Slaughter MS; Pappas PS; Naka Y; Goldstein DJ; Dembitsky WP; Giacalone JC; Ferrante J; Ascheim DD; Moskowitz AJ; Rose EA; Gelijns AC; Lowy FD;
Circulation; 2013 Feb; 127(6):691-702. PubMed ID: 23315371
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular assist device-related infections: a multicentric study.
Siméon S; Flécher E; Revest M; Niculescu M; Roussel JC; Michel M; Leprince P; Tattevin P
Clin Microbiol Infect; 2017 Oct; 23(10):748-751. PubMed ID: 28323195
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis.
Juraszek A; Smólski M; Kołsut P; Szymański J; Litwiński P; Kuśmierski K; Zakrzewska-Koperska J; Sterliński M; Dziodzio T; Kuśmierczyk M
J Cardiothorac Surg; 2021 Aug; 16(1):216. PubMed ID: 34344400
[TBL] [Abstract][Full Text] [Related]
12. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.
Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L
Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium abscessus Left Ventricle Assist Device Driveline Infections: An Emerging Pathogen?
Nunez Breton JD; Hernandez G; Simkins J; Chaparro SV
Transpl Infect Dis; 2018 Oct; 20(5):e12957. PubMed ID: 29896814
[TBL] [Abstract][Full Text] [Related]
14. Role of biofilm in Staphylococcus aureus and Staphylococcus epidermidis ventricular assist device driveline infections.
Toba FA; Akashi H; Arrecubieta C; Lowy FD
J Thorac Cardiovasc Surg; 2011 May; 141(5):1259-64. PubMed ID: 20709333
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices.
Jennings DL; Chopra A; Chambers R; Morgan JA
Artif Organs; 2014 Oct; 38(10):875-9. PubMed ID: 24571683
[TBL] [Abstract][Full Text] [Related]
16. A simple device to secure ventricular assist device driveline and prevent exit-site infection.
Baronetto A; Centofanti P; Attisani M; Ricci D; Mussa B; Devotini R; Simonato E; Rinaldi M
Interact Cardiovasc Thorac Surg; 2014 Apr; 18(4):415-7. PubMed ID: 24431003
[TBL] [Abstract][Full Text] [Related]
17. Preliminary Results of a New Treatment Strategy for Relapsed Left Ventricular Assist Device-Specific Infections.
Rotering H; Al Shakaki M; Welp H; Dell'Aquila AM
Ann Thorac Surg; 2020 Oct; 110(4):1302-1307. PubMed ID: 32169499
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal driveline infections are the predominant type of left ventricular assist device associated infections in Singapore.
Teh YE; Lim CP; Teo LLY; Soon JL; Chao VTT; Neo CL; Tan JLL; Kerk KL; Sim DKL; Tan TE; Tan BH; Cumaraswamy S; Tan TT
Infect Dis (Lond); 2019 Jun; 51(6):417-424. PubMed ID: 30985233
[TBL] [Abstract][Full Text] [Related]
20. Biofilm formation and migration on ventricular assist device drivelines.
Qu Y; McGiffin D; Kure C; Ozcelik B; Fraser J; Thissen H; Peleg AY
J Thorac Cardiovasc Surg; 2020 Feb; 159(2):491-502.e2. PubMed ID: 30955967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
